characterization of a mouse homolog of human
TNFSF14, a member of the TNF superfamily.
Cytogenet., 89, 89 – 91, (2000)
2. Montgomery, R., et al., Herpes simplex virus-1 entry
into cells mediated by a novel member
new ‘death’
adaptor molecule. Nature, 385, 86-89 (1997).
2. Ahmad, M., et al., CRADD, a novel human
apoptotic adaptor molecule for caspase-2 and
FasL/tumor necrosis factor receptor-interacting
5319
(1973).
2. Proc. Natl. Acad. Sci. USA, 85, 1257 (1988).
3. Vossler, M. R., et al., cAMP activates MAP kinase
and Elk-1 through a B-Raf- and Rap1-dependent
pathway. Cell, 89(1), 73-82 (1997
Swann, A.C. et al., J. Neurochem., 52: 1598-1604
(1989).
9. Kanzaki, A. et al., Brain Res., 569: 181-188 (1992).
10. Baker, R. et al., Cell, 1(1): 9-21 (1974).
11. Kozbor, D. et al., Hybridoma, 1(
Swann, A.C. et al., J. Neurochem., 52: 1598-1604
(1989).
9. Kanzaki, A. et al., Brain Res., 569: 181-188 (1992).
10. Baker, R. et al., Cell, 1(1): 9-21 (1974).
11. Kozbor, D. et al., Hybridoma, 1(
Immunol.,
143, 1283-89 (1989).
8. Miyake, H., et al., Calcium ionophore, ionomycin
inhibits growth of human bladder cancer cells both
in vitro and in vivo with alteration of Bcl-2 and Bax
expression
Neuron, 7, 45-57 (1991).
2. Dubel, S.J., et al., Molecular cloning of the α-1
subunit of an ω-conotoxin-sensitive calcium
channel., Proc. Natl. Acad. Sci. USA, 89,
5058-62 (1992).
3. Hell
Neuron, 7, 35-44 (1991).
2. Dubel, S.J., et al., Molecular cloning of the α-1
subunit of an ω-conotoxin-sensitive calcium
channel., Proc. Natl. Acad. Sci. USA, 89,
5058-62 (1992).
3. Hell
17. Hudak, S., et al., Blood, 85, 2747-2755 (1995).
18. Jacobsen, S. E., et al., J. Exp. Med., 181, 1357-
1363 (1995).
19. Hirayama, F., et al., Blood, 85, 1762-1768 (1995).
20. Brasel, K., et
Ben-Hur, H. and Wilchek, M., in Meth.
Enzymol., 184, 80-89 (1990).
5. Techniques in Immunocytochemistry (Academic
Press, 1983), Vol. 2, p. 236.
6. Clinical Chemistry, 37, 625-636 (1991).
7. Electrophoresis
pheochromocytoma (89%), carcinoid tumors (80%),
nonfunctioning tumors of the endocrine pancreas
(69%), and medullary carcinoma of the thyroid (50%).
Only 7% of control subjects have elevated CgA and
only 2% have
. (1938) J. Gen. Physiol. 22, 79-89
Folin, O. and Ciocalteu, V. (1927) J. Biol. Chem. 73, 627-650
NOTES:
1. This assay is based on the cited references.
2. Where Sigma Product or
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY
enzyme
UNIT DEFINITION:
One unit will hydrolyze casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per
minute at pH 7.5 at 37°C (color by Folin & Ciocalteu’s reagent).
FINAL ASSAY